Literature DB >> 9211884

Distinct roles for MAX protein isoforms in proliferation and apoptosis.

H Zhang1, S Fan, E V Prochownik.   

Abstract

MAX is a basic helix-loop-helix-leucine zipper protein that plays a central role in the transcriptional control of Myc oncoproteins. MYC-MAX heterodimers stimulate transcription, whereas MAX homodimers, or heterodimers between MAX and members of the MAD family of basic helix-loop-helix-leucine zipper proteins, repress transcription. Max exists in two major isomeric forms, MAX(L) and MAX(S), which differ from one another only by a 9-amino acid insertion/deletion. We show here that MAX(L) is much more effective at homodimeric DNA binding than MAX(S). In NIH3T3 cells, MAX(L) was able to repress a c-Myc-responsive reporter gene whereas MAX(S) either stimulated the reporter gene or had little effect on its expression. In comparison to control cell lines or those stably over-expressing MAX(S), MAX(L)-over-expressing cell lines showed reduced expression of transiently expressed or endogenous c-Myc responsive genes, grew more slowly, possessed a higher growth factor requirement, and showed accelerated apoptosis following growth factor deprivation. Differential effects on growth and apoptosis represent two previously unrecognized properties of MAX proteins. These can at least partly be explained by the differences in their DNA binding abilities and their effects on target gene expression.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9211884     DOI: 10.1074/jbc.272.28.17416

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

1.  Perturbation of the c-Myc-Max protein-protein interaction via synthetic α-helix mimetics.

Authors:  Kwan-Young Jung; Huabo Wang; Peter Teriete; Jeremy L Yap; Lijia Chen; Maryanna E Lanning; Angela Hu; Lester J Lambert; Toril Holien; Anders Sundan; Nicholas D P Cosford; Edward V Prochownik; Steven Fletcher
Journal:  J Med Chem       Date:  2015-03-30       Impact factor: 7.446

2.  A quantitative, surface plasmon resonance-based approach to evaluating DNA binding by the c-Myc oncoprotein and its disruption by small molecule inhibitors.

Authors:  Huabo Wang; Anand Ramakrishnan; Steven Fletcher; Edward V Prochownik
Journal:  J Biol Methods       Date:  2015

3.  Point mutations in c-Myc uncouple neoplastic transformation from multiple other phenotypes in rat fibroblasts.

Authors:  J Anthony Graves; Kristi Rothermund; Tao Wang; Wei Qian; Bennett Van Houten; Edward V Prochownik
Journal:  PLoS One       Date:  2010-10-28       Impact factor: 3.240

4.  Mitochondrial structure, function and dynamics are temporally controlled by c-Myc.

Authors:  J Anthony Graves; Yudong Wang; Sunder Sims-Lucas; Edward Cherok; Kristi Rothermund; Maria F Branca; Jennifer Elster; Donna Beer-Stolz; Bennett Van Houten; Jerry Vockley; Edward V Prochownik
Journal:  PLoS One       Date:  2012-05-21       Impact factor: 3.240

5.  Disruption of Myc-Max heterodimerization with improved cell-penetrating analogs of the small molecule 10074-G5.

Authors:  Huabo Wang; Jay Chauhan; Angela Hu; Kelsey Pendleton; Jeremy L Yap; Philip E Sabato; Jace W Jones; Mariarita Perri; Jianshi Yu; Erika Cione; Maureen A Kane; Steven Fletcher; Edward V Prochownik
Journal:  Oncotarget       Date:  2013-06

6.  Direct inhibition of c-Myc-Max heterodimers by celastrol and celastrol-inspired triterpenoids.

Authors:  Huabo Wang; Peter Teriete; Angela Hu; Dhanya Raveendra-Panickar; Kelsey Pendelton; John S Lazo; Julie Eiseman; Toril Holien; Kristine Misund; Ganna Oliynyk; Marie Arsenian-Henriksson; Nicholas D P Cosford; Anders Sundan; Edward V Prochownik
Journal:  Oncotarget       Date:  2015-10-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.